← Insider buys
HALO

Halozyme Therapeutics, Inc. · Healthcare

10% owner Randal J Kirk sold $5.2M of Halozyme Therapeutics, Inc.

Sold$5,221,414
$17.24Price
302,827Shares
−2%Stake

What HALO did after the filing

Prices for HALO after this filing aren't in yet.

Traded Wed, Jul 25. Filed Fri, Jul 27, 12:35 PM ET, during the session. Not investment advice.